ALARIS HOLDINGS TO CONSIDER DELISTING FROM THE JSE ALTX

The Consortium and Alaris believe that there is limited benefit for Alaris being listed on the JSE, having
not garnered sufficient institutional shareholder support to justify the limitations imposed by the
regulatory processes and the compliance- and other costs associated with and incidental to being listed
on the JSE.

Read the press release here